4//SEC Filing
Revance Therapeutics, Inc. 4
Accession 0001209191-15-080796
CIK 0001479290operating
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 9:45 PM ET
Size
9.8 KB
Accession
0001209191-15-080796
Insider Transaction Report
Form 4
Bertolino Arthur Peter
EVP and Chief Medical Officer
Transactions
- Sale
Common Stock
2015-11-17$39.11/sh−5,425$212,172→ 36,329 total - Sale
Common Stock
2015-11-17$39.55/sh−15$593→ 34,001 total - Sale
Common Stock
2015-11-17$39.55/sh−36$1,424→ 36,293 total - Sale
Common Stock
2015-11-17$39.11/sh−2,277$89,053→ 34,016 total
Footnotes (2)
- [F1]The Reporting Person sold an aggregate of 5,461 shares of restricted stock to settle a personal tax liability in connection with the November 15, 2015 vesting of certain shares of restricted stock that the Reporting Person acquired pursuant to a grant dated September 2, 2014.
- [F2]The Reporting Person sold an aggregate of 2,292 shares of restricted stock to settle a personal tax liability in connection with the November 15, 2015 vesting of certain shares of restricted stock that the Reporting Person acquired pursuant to a grant dated January 28, 2015.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001479290
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 9:45 PM ET
- Size
- 9.8 KB